JCRB0189 KYSE50
Cell information
Important Notice(s)Announcement of unavailability of KYSE series cell lines to oversea users outside of Japan
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0189 | Cell Name | KYSE50 |
|---|---|---|---|
| Profile | Stop providing for the issue of quality control. (Please contact us for more information) Poorly differentiated human squamous cell carcinoma from esophageal cancer. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 58 |
| Identity | available | Tissue for Primary Cancer | esophagus |
| Case history | esophageal cancer, lower intrathoracic esophagus, poorly differentiated squamous cell carcinoma. | Metastasis | No |
| Tissue Metastasized | Genetics | Mode of chromosome number = 105-120. DNA fingerprint indicated the cell line was unique. | |
| Life Span | infinite | Crisis PDL | |
| Morphology | epithelial-like | Character | Cell line was established from inplanted tumor of nude mice (only initial passage). |
| Classify | Established by | Shimada,Y. et.al. | |
| Registered by | Shimada,Y. | Regulation for Distribution | |
| Comment | Year | 2001 | |
| Medium | Dulbecco's modified Eagle's medium with 2% fetal calf serum. | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
| Cell Number on Passage | Race | Japanese | |
| CO2 Conc. | 5 % | Tissue Sampling | esophagus |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:9033652 | Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines. Tanaka H,Shimada Y,Imamura M,Shibagaki I,Ishizaki K Int J Cancer. 1997 Feb 7;70(4):437-42 |
| Pubmed id:8575860 | Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors. Tanaka H,Shibagaki I,Shimada Y,Wagata T,Imamura M,Ishizaki K Int J Cancer. 1996 Jan 26;65(3):372-6 |
| Pubmed id:1728357 | Characterization of 21 newly established esophageal cancer cell lines. Shimada Y,Imamura M,Wagata T,Yamaguchi N,Tobe T Cancer. 1992 Jan 15;69(2):277-84 |
| Images |
|---|
![]() ![]() ![]() |
| Movies |
|---|
|
|
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0189 | Cell Name | KYSE50 |
|---|---|---|---|
| LOT No. | 02182005 | Lot Specification | distribution |
| Medium | Dulbecco's modified Eagle's medium with 2% fetal bovine serum (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
| Cell Density at Seeding | 1.5 - 2.0 x 10^5 cells/ml | Methods for Passages | 200 units/ml trypsin and 0.01% EDTA |
| Doubling Time | ca. 2-3 days | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
| Viability at cell freezing (%) | 87.4 | Antibiotics Used | free |
| Passage Number | P6 at bank | PDL | |
| Sterility: MYCOPLASMA | + | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0189 | Cell Name | KYSE50 |
|---|---|---|---|
| LOT No. | 02242015 | Lot Specification | distribution |
| Medium | RPMI1640(GIBCO) and Ham's F12 medium(SiGMA)(1/1) with 2% heat inactivated fetal bovine serum(SIGMA12J396). | Temperature | 37 C |
| Cell Density at Seeding | 1.80-5.22x10^4cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 1mM EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.32x10^6 |
| Viability at cell freezing (%) | 85.7 | Antibiotics Used | |
| Passage Number | p10* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11 D13S317:11 D7S820:10 D16S539:10,12 VWA:17,19 TH01:8 AM:X TPOX:11 CSF1PO:11,12 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information | Acholeplasma has eliminated with Plasmocin(Final concentration 25 ug/ml). Expected viability (defrost ampoule) 88.0%. |
| Images |
|---|
|
|


